Ergomed Group Appoints Jovan Willford as CEO to Lead Growth Strategy
- Jovan Willford, former Cytel CEO and IQVIA executive, assumes Ergomed Group leadership effective November 2, 2026.
- Willford brings 15+ years in life sciences data, analytics, and technology-enabled service delivery, with prior experience leading clinical businesses across 72 countries at IQVIA.
Operational Impact
Willford's stated priorities in AI application and technology-enabled service delivery may signal Ergomed's strategic shift toward data analytics and automation in clinical trial operations, potentially affecting how the CRO competes on efficiency and regulatory compliance.
Source: PrimeVigilance News RSS